Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

BRTX holding history

BioRestorative Therapies, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BRTX overviewAll 13F holders of BRTXFull Q4 2025 holdings

Shares (Q4 2025)
88,778
Value
$103.9K
% of portfolio
<0.1%
Quarters held
17
Since Q4 2021
Holdings of BRTX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202588,778$103.9K<0.1%00.0%UnchangedHolders
Q3 202588,778$127.0K<0.1%+59,048+198.6%AddedHolders
Q2 202529,730$49.6K<0.1%00.0%UnchangedHolders
Q1 202529,730$52.9K<0.1%+9,258+45.2%AddedHolders
Q4 202420,472$29.3K<0.1%00.0%UnchangedHolders
Q3 202420,472$35.6K<0.1%00.0%UnchangedHolders
Q2 202420,472$41.6K<0.1%00.0%UnchangedHolders
Q1 202420,472$28.3K<0.1%−100,161−83.0%ReducedHolders
Q4 2023120,633$209.9K<0.1%−17,185−12.5%ReducedHolders
Q3 2023137,818$246.7K<0.1%+10,862+8.6%AddedHolders
Q2 2023126,956$559.9K<0.1%+1,000+0.8%AddedHolders
Q1 2023125,956$428.3K<0.1%−9,090−6.7%ReducedHolders
Q4 2022135,046$371.4K<0.1%00.0%UnchangedHolders
Q3 2022135,046$436.0K<0.1%00.0%UnchangedHolders
Q2 2022135,046$398.0K<0.1%00.0%UnchangedHolders
Q1 2022135,046$706.0K<0.1%−17,408−11.4%ReducedHolders
Q4 2021152,454$662.0K<0.1%+152,454NewHolders